Roger Pharma Morphix-DAC | CJC-1295 DAC

Roger Pharma Morphix-DAC | CJC-1295 DAC

Roger Pharma Morphix-DAC contains CJC-1295 with DAC (Drug Affinity Complex), a long-acting growth hormone-releasing hormone (GHRH) analog developed for scientific and laboratory research. Unlike standard CJC-1295 without DAC, this modified peptide remains active in the body for a significantly longer period due to its Drug Affinity Complex technology, allowing sustained stimulation of growth hormone release.

In research settings, CJC-1295 with DAC has been investigated for its ability to increase natural growth hormone (GH) and insulin-like growth factor-1 (IGF-1) levels over an extended period. Scientists have explored its potential applications in body composition, muscle recovery, tissue regeneration, sleep quality, metabolism, and healthy aging. Because of its prolonged half-life, researchers often prefer CJC-1295 with DAC when studying continuous GH secretion rather than frequent pulsatile dosing.

Morphix-DAC is manufactured by Roger Pharma for laboratory and research purposes only. It is intended for qualified research professionals and is not approved for human consumption or medical treatment.

What is CJC-1295 with DAC?

CJC-1295 with DAC is a synthetic peptide derived from Growth Hormone Releasing Hormone (GHRH). The addition of the Drug Affinity Complex (DAC) allows the peptide to bind with albumin in circulation, dramatically increasing its half-life compared to standard GHRH peptides.

This extended activity enables researchers to examine prolonged physiological responses, making it valuable for studies involving:

• Growth hormone secretion
• IGF-1 production
• Protein synthesis
• Muscle tissue recovery
• Fat metabolism
• Anti-aging mechanisms
• Exercise performance
• Sleep physiology

Unlike direct growth hormone administration, CJC-1295 with DAC encourages the body’s natural production of GH, making it an interesting subject in endocrine research.

Potential Research Applications

Researchers have investigated Morphix-DAC in multiple scientific areas, including:

Growth Hormone Release

One of the primary research interests is its ability to stimulate the pituitary gland to release endogenous growth hormone over several days following administration.

Muscle Recovery Studies

Laboratory studies have explored whether increased GH and IGF-1 levels may support faster recovery after intense exercise and improve tissue repair mechanisms.

Body Composition Research

Scientists continue evaluating the peptide’s role in lean body mass development and reduction of body fat through improved metabolic activity.

Sleep Quality

Growth hormone secretion naturally increases during deep sleep. Researchers study whether sustained GH stimulation influences sleep architecture and recovery.

Healthy Aging Research

Age-related decline in GH production has prompted investigations into whether CJC-1295 with DAC may help maintain physiological functions associated with aging.

Connective Tissue Research

Some laboratory models evaluate its possible role in collagen synthesis and connective tissue maintenance.

Features of Roger Pharma Morphix-DAC

• Contains CJC-1295 with Drug Affinity Complex (DAC)
• Long-acting peptide formulation
• Extended half-life compared to CJC-1295 without DAC
• Supports prolonged GH stimulation in research models
• Suitable for endocrine and metabolic research
• Manufactured by Roger Pharma
• Intended strictly for laboratory research use

Why Researchers Choose CJC-1295 with DAC

Compared with shorter-acting GHRH analogs, CJC-1295 with DAC offers several research advantages:

• Longer biological activity
• Reduced dosing frequency in research protocols
• Sustained GH and IGF-1 elevation
• Stable plasma concentrations
• Useful for long-term endocrine studies

These characteristics make it a valuable peptide for investigating chronic physiological responses.

Storage Guidelines

To preserve peptide stability during research:

• Store refrigerated between 2°C and 8°C before reconstitution.
• After reconstitution, maintain refrigeration.
• Protect from direct sunlight.
• Avoid repeated freeze-thaw cycles.
• Use sterile laboratory handling techniques.

Research Information

Compound: CJC-1295 with DAC

Brand: Roger Pharma

Category: Growth Hormone Releasing Hormone (GHRH) Analog

Research Use: Laboratory Research Only

Mechanism: Stimulates endogenous growth hormone release

Half-Life: Significantly longer than CJC-1295 without DAC

Frequently Asked Questions

What is Morphix-DAC?

Morphix-DAC is Roger Pharma’s research formulation containing CJC-1295 with Drug Affinity Complex, designed for laboratory investigations involving growth hormone physiology.

What makes DAC different?

The Drug Affinity Complex binds to albumin, extending the peptide’s half-life and allowing prolonged biological activity compared to non-DAC versions.

Is Morphix-DAC approved as a medicine?

No. Morphix-DAC is supplied for research purposes only and is not approved for diagnosing, treating, curing, or preventing any disease.

Can researchers combine it with other peptides?

Some scientific studies investigate peptide combinations, but experimental protocols depend on specific research objectives and should follow applicable laboratory standards.

How should it be stored?

Store refrigerated between 2°C and 8°C and protect it from excessive heat, light, and repeated freeze-thaw cycles.

Disclaimer

Roger Pharma Morphix-DAC (CJC-1295 with DAC) is intended strictly for laboratory and scientific research purposes only. This product is not approved for human consumption, therapeutic use, or veterinary use. Any information provided is for educational and research reference only and should not be interpreted as medical advice or treatment recommendations.